ZyVersa Therapeutics, Inc. (ZVSA) EBIT (2022 - 2026)
ZyVersa Therapeutics' EBIT was -$1.3 million in Q1 2026, compared with -$2.14 million a year earlier.
Powered by 
Analysis
ZyVersa Therapeutics, Inc. (ZVSA) EBIT (2022 - 2026) Analysis & Trends
On a trailing twelve-month basis, ZyVersa Therapeutics' EBIT was -$24.65 million through Mar 31, 2026; for FY2025, it was -$25.49 million.
- In earlier years, EBIT was -$9.14 million in FY2024, -$107.75 million in FY2023 and -$13.01 million in FY2022.
- Quarterly EBIT has moved between -$86.33 million (Q2 2023) and -$498,752 (Q2 2022) over five years.
- Per Business Quant data, ZVSA's EBIT in the three quarters before Q1 2026 was -$551,858 (Q4 2025), -$20.75 million (Q3 2025) and -$2.04 million (Q2 2025).
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -1.30 Mn |
| Dec 31, 2025 | -551,858.00 |
| Sep 30, 2025 | -20.75 Mn |
| Jun 30, 2025 | -2.04 Mn |
| Mar 31, 2025 | -2.14 Mn |
| Dec 31, 2024 | -1.29 Mn |
| Sep 30, 2024 | -2.27 Mn |
| Jun 30, 2024 | -2.75 Mn |
| Mar 31, 2024 | -2.83 Mn |
| Dec 31, 2023 | -13.93 Mn |
| Sep 30, 2023 | -2.90 Mn |
| Jun 30, 2023 | -86.33 Mn |
| Mar 31, 2023 | -4.59 Mn |
| Jun 30, 2022 | -498,752.00 |
| Mar 31, 2022 | -801,048.00 |
API Access
ZyVersa Therapeutics, Inc. EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=ZVSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "ZVSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=ZVSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();